Maximus (NYSE:MMS – Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 7.900-8.200 for the period, compared to the consensus estimate of 8.430. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.
Analyst Ratings Changes
A number of research firms have weighed in on MMS. Weiss Ratings lowered shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Check Out Our Latest Research Report on Maximus
Maximus Trading Up 2.2%
Maximus (NYSE:MMS – Get Free Report) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the firm earned $2.16 earnings per share. The business’s quarterly revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Research analysts expect that Maximus will post 8.43 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Friday, August 14th. Maximus’s dividend payout ratio (DPR) is 19.76%.
Hedge Funds Weigh In On Maximus
Hedge funds and other institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC purchased a new position in Maximus during the 3rd quarter worth $32,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after acquiring an additional 304 shares during the period. Canada Pension Plan Investment Board purchased a new position in Maximus during the second quarter worth about $35,000. Danske Bank A S acquired a new stake in Maximus in the third quarter valued at about $55,000. Finally, Kestra Advisory Services LLC purchased a new stake in Maximus in the 4th quarter valued at approximately $89,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- AST SpaceMobile’s Latest BlueBird Launch Raises the Stakes Ahead of Q2 Earnings
- Buy the Dip or Run: 3 Software Stocks Down 50% Face Their Moment of Truth
- IonQ Sparks a Quantum Grid Revolution
- No Hangover: Revisiting Microsoft One Week After Earnings
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
